Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 studyHarry J M Groen, Hannie Sietsma, Andrew Vincent, et al.
Acta Oncologica (Stockholm, Sweden)|February 13, 2025
Rising incidence of radiation pneumonitis after adjuvant durvalumab in NSCLC patients treated with concurrent chemoradiotherapyRutger H Stoffers, Anne G H Niezink, Olga Chouvalova, et al.
Radiation Oncology (London, England)|September 2, 2014
Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancerGerald S M A Kerner, Leon F A van Dullemen, Erwin M Wiegman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 16, 2023
External validation of NTCP-models for radiation pneumonitis in lung cancer patients treated with chemoradiotherapyAnne G H Niezink, Arjen van der Schaaf, Robin Wijsman, et al.
Lung Cancer (Amsterdam, Netherlands)|August 17, 2021
Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinomaChristi M J Steendam, Robert Peric, Nico C van Walree, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2015
An instrument dedicated for modelling of pulmonary radiotherapyAnne G H Niezink, Nienke J Dollekamp, Harriet J Elzinga, et al.
Clinical Lung Cancer|April 22, 2025
The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort StudyMart P Kicken, Rob Ter Heine, Intissar Azarfane, et al.
Pageof 2